You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy

Authors

  • Shixiang Wang Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Yi Xiong Xiangya School of Medicine, Central South University, Changsha, People's Republic of China Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, People's Republic of China Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China PubMed articlesGoogle scholar articles
  • Yihao Zhang Xiangya School of Medicine, Central South University, Changsha, People's Republic of China Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, People's Republic of China Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China PubMed articlesGoogle scholar articles
  • Haitao Wang Center for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, People's Republic of China PubMed articlesGoogle scholar articles
  • Minjun Chen Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China PubMed articlesGoogle scholar articles
  • Jianfeng Li State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Peng Luo Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Yung-Hung Luo Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Markus Hecht Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg, Germany PubMed articlesGoogle scholar articles
  • Benjamin Frey Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Udo Gaipl Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Xuejun Li Xiangya School of Medicine, Central South University, Changsha, People's Republic of China Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, People's Republic of China Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China PubMed articlesGoogle scholar articles
  • Qi Zhao State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Hu Ma Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China PubMed articlesGoogle scholar articles
  • Jian-Guo Zhou Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles

Citation

Wang S, Xiong Y, Zhang Y, et al
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy
Journal for ImmunoTherapy of Cancer 2024;12:e008040. doi: 10.1136/jitc-2023-008040
Online issue publication 
January 11, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.